Zoetis Introduces ONE SHOT® BVD
Zoetis Introduces ONE SHOT® BVD
Vaccine helps provide respiratory protection for beef and dairy cattle
Zoetis today announced the addition of ONE SHOT® BVD to its comprehensive vaccine portfolio. The new vaccine helps provide combined respiratory protection against Mannheimia haemolytica and bovine viral diarrhea (BVD) Types 1 and 2 viruses in a single dose.
ONE SHOT BVD helps cattle producers expand respiratory vaccination programs that currently include INFORCE™ 3 respiratory vaccine, which is used to help protect beef and dairy calves. Young calves need additional respiratory protection due to underdeveloped immune systems and exposure to environmental stressors, which can cause them to fall victim to respiratory infection.
“The superior respiratory protection of INFORCE 3 against bovine respiratory syncytial virus (BRSV) and the complementary M. haemolytica and BVD protection of ONE SHOT BVD offers producers a convenient and effective way to help combat bovine respiratory disease (BRD),” said Jon Seeger, DVM, managing veterinarian, Zoetis Cattle and Equine Technical Services. “These vaccines help provide the respiratory protection calves need until they are sold or move to the next production phase.”
As the second-most significant disease impacting dairy operations1 and the leading cause of death in beef calves between three weeks of age and weaning,2 BRD can negatively impact the health, productivity and profitability of young calves.
“INFORCE 3 and ONE SHOT BVD help provide the antigens that young calves need to build their immunity before being commingled or turned out to pasture,” Seeger continued. “Using the right antigens, at the right time, helps offer comprehensive respiratory protection from BRSV, infectious bovine rhinotracheitis (IBR) virus, parainfluenza 3 (PI3) virus, M. haemolytica and BVD Types 1 and 2 viruses.”
ONE SHOT BVD is available in 10- or 50-dose vials and can be purchased through veterinarians or animal health retailers.
Zoetis (zô-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. In 2013, the company generated annual revenue of $4.6 billion. With approximately 9,800 employees worldwide at the beginning of 2014, Zoetis has a local presence in approximately 70 countries, including 28 manufacturing facilities in 11 countries. Its products serve veterinarians, livestock producers and people who raise and care for farm and companion animals in 120 countries. For more information, visit www.zoetis.com
Zoetis is the proud sponsor with the Smithsonian Institution Traveling Exhibition Service and the American Veterinary Medical Association of the mobile educational exhibit Animal Connections: Our Journey Together. Families visiting the exhibit will explore the vast bonds between people and animals and learn about the important role veterinarians play in protecting animal and human health. For more information, visit www.zoetis.com/animal-connections-tour